Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eiger Biopharma
(NQ:
EIGR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eiger Biopharma
< Previous
1
2
Next >
Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate
November 16, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
November 16, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
November 15, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
EIGER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
November 14, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ROSEN, A TOP RANKED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
November 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Eiger Biopharmaceutials, Inc. (EIGR)
November 09, 2022
From
Robbins LLP
Via
Business Wire
NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc.
November 09, 2022
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Eiger BioPharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties.
Via
SBWire
EQUITY ALERT: Rosen Law Firm Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
November 09, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
November 09, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
November 08, 2022
From
The Schall Law Firm
Via
Business Wire
NASDAQ:EIGR Investor Notice: Investigation over Possible Securities Laws Violations by Eiger BioPharmaceuticals, Inc.
September 21, 2022
San Diego, CA -- (SBWIRE) -- 09/21/2022 -- Eiger BioPharmaceuticals, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements.
Via
SBWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.